Author

Bin Sun

Jiangnan UniversityORCID 0000-0001-8622-888XUnclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Bin Sun6 papers · GlaxoSmithKline (United Kingdom)

Biology Disciplines

Click to filter author papers

Bioinformatics· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:benchmarking· 1 Assay:bulk RNA-seq· 1 Research Focus:differential expression· 1 Organism:human· 1 Approach:machine learning (classical)· 1 Assay:scRNA-seq· 1 Approach:statistical model· 1

Frequent Co-Authors

Chengze WangiD· 1 shared Wei Liu· 1 shared Yiqiao Lu· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

3 top collaborators · 3 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBioinformatics

Chengze WangORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

BioinformaticsbioRxivPreprintApr 30, 2026

Systems Pharmacology Reveals Type I Interferon and Myeloid-Like B Cell Reprogramming as Druggable Axes in Antiphospholipid Syndrome

Bin Sun, Yiqiao Lu, Wei Liu, Chengze Wang

The paper identifies druggable targets in antiphospholipid syndrome using systems pharmacology, revealing two key modules linked to interferon-I signaling and degranulation pathways.

DOI 10.64898/2026.04.28.721277

humanbulk RNA-seq

𝕏 PostBluesky